Copyright
©The Author(s) 2016.
World J Hepatol. Sep 28, 2016; 8(27): 1149-1154
Published online Sep 28, 2016. doi: 10.4254/wjh.v8.i27.1149
Published online Sep 28, 2016. doi: 10.4254/wjh.v8.i27.1149
Patients | Controls | |
At listing | ||
n | 36 | 72 |
Age, median (IQR) | 58 (14) | 60 (11) |
Male, n (%) | 23 (64) | 46 (64) |
INR, median (IQR) | 1.8 (0.6) | 1.9 (0.7) |
Total Bilirubin, median (IQR) | 8.9 (19.3) | 5 (7.7) |
Creatinine, median (IQR) | 2.1 (2.4) | 1.5 (2) |
Albumin, median (IQR) | 3.2 (0.9) | 2.9 (1) |
MELD, median (IQR) | 27 (11) | 24 (11) |
At transplant | ||
n | 19 | 38 |
Age, median (IQR) | 56 (17) | 55 (13) |
Male, n (%) | 13 (68) | 26 (68) |
INR, median (IQR) | 1.6 (0.5) | 1.9 (0.8) |
Total Bilirubin, median (IQR) | 8.3 (12.1) | 6 (5.7) |
Creatinine, median (IQR) | 2.6 (2.9) | 1.3 (1.3) |
Albumin, median (IQR) | 2.9 (0.8) | 2.8 (1) |
MELD, median (IQR) | 24 (13) | 25 (9) |
- Citation: Hajifathalian K, Humberson A, Hanouneh MA, Barnes DS, Arora Z, Zein NN, Eghtesad B, Kelly D, Hanouneh IA. Ohio solid organ transplantation consortium criteria for liver transplantation in patients with alcoholic liver disease. World J Hepatol 2016; 8(27): 1149-1154
- URL: https://www.wjgnet.com/1948-5182/full/v8/i27/1149.htm
- DOI: https://dx.doi.org/10.4254/wjh.v8.i27.1149